Method of Determining Response to Treatment with Immunomodulatory Composition
The present invention provides a method for accurately determining the likelihood that a subject will respond to treatment with an immunomodulatory composition comprising detecting one or more markers in a sample from the subject, wherein at least one markers is linked to a single nucleotide polymorphism (SNP) set forth in Table 1 or 3-5, and processes for selecting suitable subjects for therapy or for continued therapy, and for providing appropriate therapy to subjects, based on the assay results.
Patents:WO 2,010,144,946
Inventor(s):
GEORGE JACOB [AU]; BOOTH DAVID [AU]; SUPPIAH VIJAYAPRAKASH [AU]; STEWART GRAEME [AU]
Type of Offer:
Sale
« More Medical Patents